Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systems

scientific article published on 01 September 1989

Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systems is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1023/A:1015971429942
P698PubMed publication ID2813273

P2093author name stringH L Fung
G A Brazeau
P2860cites workLegitimate Indications for Intramuscular InjectionsQ39779648
An in vitro model to evaluate muscle damage following intramuscular injectionsQ44165651
Polyethylene glycol as a solvent for diazepam: bioavailability and clinical effects after intramuscular administration, comparison of oral, intramuscular and rectal administration, and precipitation from intravenous solutionsQ44763807
Solubilization by cosolvents III: Diazepam and benzocaine in binary solvents.Q51827264
Solubilization by cosolvents I: organic solutes in propylene glycol-water mixtures.Q52430866
The loss of creatine phosphokinase (CK) from intramuscular injection sites in rabbits. A predictive tool for local toxicityQ66918892
Intramuscular injection-site complicationsQ67357053
Indocyanine green: pharmacokinetics in the rabbit and relevant studies of its stability and purityQ69551330
Muscular toxicity of polyols. IVQ70628841
Solubilization by cosolvents II: Phenytoin in binary and ternary solventsQ70757120
Response of dogs to subcutaneous injections of various concentrations of propylene glycol with waterQ71288327
Hemolysis study of aqueous polyethylene glycol 400, propylene glycol and ethanol combinations in vivo and in vitroQ71361758
A study of the polyethylene glycols as vehicles for intramuscular and subcutaneous InjectionQ75995902
The toxicology of the polyethylene glycolsQ80725909
P433issue9
P304page(s)766-771
P577publication date1989-09-01
P1433published inPharmaceutical ResearchQ7180737
P1476titleUse of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systems
P478volume6

Reverse relations

cites work (P2860)
Q46441768Acute changes in muscle blood flow and concomitant muscle damage after an intramuscular administration.
Q55361692Approach-aversion in calves following injections.
Q93929665Assessment of the myotoxicity of pharmaceutical buffers using an in vitro muscle model: effect of pH, capacity, tonicity, and buffer type
Q74602159Current perspectives on pain upon injection of drugs
Q39020837If Euhydric and Isotonic Do Not Work, What Are Acceptable pH and Osmolality for Parenteral Drug Dosage Forms?
Q47798379Impact of intramuscular administration of lipid-soluble and water-soluble vehicles into regenerating muscle at the distinct phases of skeletal muscle regeneration
Q39531684In vitro assessment of new embolic liquids prepared from preformed polymers and water-miscible solvents for aneurysm treatment
Q74628270In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery
Q38303446Longitudinal analysis of gene expression in porcine skeletal muscle after post-injection local injury
Q35698278Solubilizing excipients in oral and injectable formulations

Search more.